Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors

Cancer Treatment Reviews

Volumn 36, Issue 2, 2010, Pages 101-109

  Azim, Hatem A ^a,b   Peccatori, Fedro A ^c   Pavlidis, Nicholas ^d  

^a CAIRO UNIVERSITY   (Egypt)

^b JULES BORDET INSTITUTE   (Belgium)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ERLOTINIB; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LAPATINIB; LOMUSTINE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; PLATINUM COMPLEX; PREDNISONE; PROCARBAZINE; TAMOXIFEN; TEMOZOLOMIDE; TRASTUZUMAB; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADENOID CYSTIC CARCINOMA; ANEMIA; BICUSPID AORTIC VALVE; BONE METASTASIS; BRACHYTHERAPY; BRAIN TUMOR; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLEFT PALATE; CLINICAL PRACTICE; CLUBFOOT; COLORECTAL CANCER; CONGENITAL MALFORMATION; DISEASE FREE SURVIVAL; DOWN SYNDROME; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECLAMPSIA; FETUS DEATH; HEAD AND NECK TUMOR; HUMAN; HYPERMETROPIA; HYPOCALCEMIA; IDIOPATHIC DISEASE; IMMUNOTHERAPY; KAPOSI SARCOMA; KIDNEY POLYCYSTIC DISEASE; LUNG CANCER; MELANOMA; MENTAL DEFICIENCY; MICROPHTHALMIA; NEUROBLASTOMA; OLIGOHYDRAMNIOS; OVARY CANCER; OVERALL SURVIVAL; PHYSICAL DISABILITY; PREECLAMPSIA; PREGNANCY; RESPIRATORY DISTRESS; REVIEW; SARCOMA; SOLID TUMOR; SPONTANEOUS ABORTION; SYNDACTYLY; SYSTEMATIC REVIEW; TERATOGENICITY; UTERINE CERVIX CANCER; VESICOURETERAL REFLUX; DOSE RESPONSE; FEMALE; METHODOLOGY; NEOPLASM; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 77950625983     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2009.11.007     Document Type: Review

References (141)

1. Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 2006, 42:126-140.
2. Berkowitz G.S., Skovron M.L., Lapinski R.H., Berkowitz R.L. Delayed childbearing and the outcome of pregnancy. N Engl J Med 1990, 322:659-664.
3. Loibl S., von Minckwitz G., Gwyn K., Ellis P., Blohmer J.U., Schlegelberger B., et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006, 106:237-246.
4. Hahn K.M., Johnson P.H., Gordon N., Kuerer H., Middleton L., Ramirez M., et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006, 107:1219-1226.
5. Peccatori F.A., Azim H.A., Scarfone G., Gadducci A., Bonazzi C., Gentilini O., et al. Weekly epirubicin in the treatment of gestational breast cancer. Breast Cancer Res Treat 2009, 115:591-594.
6. Garcia-Manero M., Royo M.P., Espinos J., Pino L., Alcazar J.L., Lopez G. Pregnancy associated breast cancer. Eur J Surg Oncol 2009, 35:215-218.
7. Jameel A., Jamil S.N. Safety of cytotoxic chemotherapy during pregnancy. J Pak Med Assoc 2007, 57:449-452.
8. Wong A.S., Lim E.H., Robless P.A., Back M.F., Wang S.C., Ang B.K., et al. A pregnant lady with aggressive breast cancer. Ann Acad Med Singapore 2007, 36:448-449.
9. Schotte K., Cocguyt V., Van den Broecke R., Dhondt M., Van Belle S. Breast cancer during pregnancy: cases and review of treatment and prognosis. Acta Clin Belg 2000, 55:102-109.
10. Zemlickis D., Lishner M., Degendorfer P., Panzarella T., Sutcliffe S.B., Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Int Med 1992, 152:573-576.
11. Dreicer R., Love R.R. High total dose 5-fluorouracil treatment during pregnancy. Wis Med J 1991, 90:582-583.
12. Paskulin G.A., Gazzola Zen P.R., de Camargo Pinto L.L., Rosa R., Graziadio C. Combined chemotherapy and teratogenicity. Birth Defects Res A Clin Mol Teratol 2005, 73:634-637.
13. Abellar R.G., Pepperell J.R., Greco D., Gundogan F., Kostadinov S., Schwartz J., et al. Effects of chemotherapy during pregnancy on the placenta. Pediatr Dev Pathol 2009, 12:35-41.
14. Skrablin S., Banović V., Matković V. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy. Eur J Obstet Gynecol Reprod Biol 2007, 133:251-252.
15. De Carolis S., Grimolizzi F., Garofalo S., Fatigante G., Ferrazzani S., Carducci B., et al. Cancer in pregnancy: results of a series of 32 patients. Anticancer Res 2006, 26:2413-2418.
16. Ring A.E., Smith I.E., Jones A., Shannon C., Galani E., Ellis P.A. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005, 23:4192-4197.
17. Peretz B., Peretz T. The effect of chemotherapy in pregnant women on the teeth of offspring. Pediatr Dent 2003, 25:601-604.
18. Meyer-Wittkopf M., Barth H., Emons G., Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy. Case report and review of the literature. Ultrasound Obstet Gynecol 2001, 18:62-66.
19. Ginopoulos P.V., Michail G.D., Kourounis G.S. Pregnancy associated breast cancer: a case report. Eur J Gynaecol Oncol 2004, 25:261-263.
20. Müller T., Hofmann J., Steck T. Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996, 67:197-198.
21. Matsunoki A., Yoshino H., Takayanagi T., Kadoya S., Kotake M., Ishiguro K., et al. Breast cancer during pregnancy-a case report. Gan To Kagaku Ryoho 2008, 35:991-993.
22. Barni S., Ardizzoia A., Zanetta G., Strocchi E., Lissoni P., Tancini G. Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report. Tumori 1992, 78:349-350.
23. Eedarapalli P., Biswas N., Coleman M. Epirubicin for breast cancer during pregnancy: a case report. J Reprod Med 2007, 52:730-732.
24. Mathelin C., Annane K., Dufour P., Liegeois P., Bergerat J.P. Chemotherapy for breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005, 123:260-262.
25. Bedard P.L., Cardoso F. Recent advances in adjuvant systemic therapy or early-stage breast cancer. Ann Oncol 2008, 19(Suppl 5):122-127.
26. Potluri V., Lewis D., Burton G.V. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 2006, 7:167-170.
27. Nieto Y., Santisteban M., Aramendía J.M., Fernández-Hidalgo O., García-Manero M., López G. Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer 2006, 6:533-534.
28. Gonzalez-Angulo A.M., Walters R.S., Carpenter R.J., Ross M.I., Perkins G.H., Gwyn K., et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 2004, 5:317-319.
29. Lycette J.L., Dul C.L., Munar M., Belle D., Chiu S.Y., Koop D.R., et al. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer 2006, 7:342-344.
30. Gadducci A., Cosio S., Fanucchi A., Nardini V., Roncella M., Conte P.F., et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 2003, 23:5225-5229.
31. Pereg D., Lishner M. Maternal and fetal effects of systemic therapy in the pregnant woman with cancer. Recent Results Cancer Res 2008, 178:21-38.
32. Bawle E.V., Conard J.V., Weiss L. Adult and two children with fetal methotrexate syndrome. Teratology 1998, 57:51-55.
33. Peres R.M., Sanseverino M.T., Guimaraes J.L., Coser V., Giuliani L., Moreira R.K., et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 2001, 34:1551-1559.
34. Donnenfeld A.E., Pastuszak A., Noah J.S., Schick B., Rose N.C., Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994, 49:79-81.
35. Green F.L. Gestational breast cancer: a ten-year experience. South Med J 1988, 81:1509-1511.
36. Cuvier C., Espie M., Extra J.M., Marty M. Vinorelbine in pregnancy. Eur J Cancer 1997, 33:168-169.
37. Turchi J.J., Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988, 61:435-440.
38. Sharma J.B., Pushparaj M., Kumar S., Roy K.K., Raina V., Malhotra N. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraduct breast carcinoma. Arch Gynecol Obstet 2009, 279:415-417.
39. Gainford M.C., Clemons M. Breast cancer in pregnancy: are taxanes safe?. Clin Oncol (R Coll Radiol) 2006, 18:159.
40. De Santis M., Lucchese A., De Carolis S., Ferrazani S., Caruso A. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care 2000, 9:235-237.
41. Sekar R., Stone P.R. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol 2007, 110:507-510.
42. Willemse P.H., van der Sijde R., Sleijfer D.T. Combination chemotherapy and radiation for stage IV breast cancer during pregnancy. Gynecol Oncol 1990, 36:281-284.
43. Tobias J.S., Bloom H.J. Doxorubicin in pregnancy. Lancet 1980, 1:776.
44. Minsker D.H., Manson J.M., Peter C.P. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 1993, 121:217-223.
45. Djokanovic N., Klieger-Grossmann C., Koren G. Does treatment with bisphosphonates endanger the human pregnancy?. J Obstet Gynaecol Can 2008, 30:1146-1148.
46. Levy S., Fayez I., Taguchi N., Han J.Y., Aiello J., Matsui D., et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone 2009, 44:428-430.
47. Azim H., Azim H.A. Targeting Her-2/neu in breast cancer: as easy as this!. Oncology 2008, 74:150-157.
48. Watson W.J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 2005, 105:642-643.
49. Fanale M.A., Uyei A.R., Theriault R.L., Adam K., Thompson R.A. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 2005, 6:354-356.
50. Waterston A.M., Graham J. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 2006, 24:321-322.
51. Kelly H., Graham M., Humes E., Dorflinger L.J., Boggess K.A., O'Neil B.H., et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 2006, 7:339-341.
52. Bader A.A., Schlembach D., Tamussino K.F., Pristauz G., Petru E. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007, 8:79-81.
53. Shrim A., Garcia-Bournissen F., Maxwell C., Farine D., Koren G. Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy-case report and updated literature review. Reprod Toxicol 2007, 23:611-613.
54. Witzel I.D., Müller V., Harps E., Janicke F., Dewit M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008, 19:191-192.
55. Berveiller P., Mir O., Sauvanet E., Antoine E.C., Goldwasser F. Ectopic pregnancy in a breast cancer patient receiving trastuzumab. Reprod Toxicol 2008, 25:286-288.
56. Pant S., Landon M.B., Blumenfeld M., Farrar W., Shapiro C.L. Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol 2008, 26:1567-1569.
57. Weber-Schoendorfer C., Schaefer C. Trastuzumab exposure during pregnancy. Reprod Toxicol 2008, 25:390-391.
58. Warraich Q., Smith N. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios. J Obstet Gynaecol 2009, 29:147-148.
59. Beale J.M., Tuohy J., McDowell S.J. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am J Obstet Gynecol 2009, 201:e12-e14.
60. Azim H.A., Peccatori F.A., Liptrott S.J., Catania C., Goldhirsch A. Breast cancer and pregnancy: How safe is trastuzumab?. Nat Rev Clin Oncol 2009, 6:367-370.
61. Azim H., Azim H.A., Escudier B. Trastuzumab versus lapatinib: the cardiac side of the story. Cancer Treat Rev 2009, 35:633-638.
62. Press M.F., Cordon-Cardo C. Slamon DJ: expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 1990, 5:953-962.
63. Iguchi T., Hirokawa M., Takasugi M. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology 1986, 42:1-11.
64. Tewari K., Bonebrake R.G., Asrat T., Shanberg A.M. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancer 1997, 350:183.
65. Cullins S.L., Pridjian G., Sutherland C.M. Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. J Am Med Assoc 1994, 271:1905-1906.
66. Oksuzoglu B., Guler N. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol 2002, 104:79.
67. Isaacs R.J., Hunter W., Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol 2001, 80:405-408.
68. Barthelmes L., Gateley C.A. Tamoxifen and pregnancy. Breast 2004, 13:446-451.
69. Clark S. Prophylactic tamoxifen. Lancet 1993, 342:168.
70. Karimi Zarchi M., Behtash N., Modares Gilani M. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet 2008, 277:75-78.
71. Hubalek M., Smekal-Schindelwig C., Zeimet A.G., Sergi C., Brezinka C., Mueller-Holzner E., et al. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Arch Gynecol Obstet 2007, 276:179-183.
72. Machado F., Vegas C., Leon J., Perez A., Sanchez R., Parrilla J.J., et al. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol 2007, 105:446-450.
73. Motegi M., Takakura S., Takano H., Tanaka T., Ochiai K. Adjuvant chemotherapy in a pregnant women with endodermal sinus tumor of the ovary. Obstet Gynecol 2007, 109:537-540.
74. Robova H., Rob L., Hrehorcak M., Zoban P., Prusa R. Endodermal sinus tumor diagnosed in pregnancy: a case report. Int J Gynecol Cancer 2007, 17:914-916.
75. Ghaemmaghami F., Hasanzadeh M. Good fetal outcome of pregnancies with gynecologic cancer conditions: cases and literature review. Int J Gynecol Cancer 2006, 16(Suppl 1):225-230.
76. Han J.Y., Nava-Ocampo A.A., Kim T.J., Shim J.U., Park C.T. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant germ cell tumors: report of 2 cases. Reprod Toxicol 2005, 19:557-561.
77. Malhotra N., Sood M. Ovarian germ cell neoplasm in pregnancy. Eur J Gynaecol Oncol 2000, 21:396.
78. Elit L., Bocking A., Kenyon C., Natale R. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol 1999, 72:123-127.
79. Tomlinson M.W., Treadwell M.C., Deppe G. Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy. Eur J Gynaecol Oncol 1997, 18:44-46.
80. Horbelt D., Delmore J., Meisel R., Cho S., Roberts D., Logan D. Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol 1994, 84:662-664.
81. Buller R.E., Darrow V., Manetta A., Porto M., DiSaia P.J. Conservative surgical management of dysgerminoma concomitant with pregnancy. Obstet Gynecol 1992, 79:887-890.
82. Christman J.E., Teng N.N., Lebovic G.S., Sikic B.I. Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecol Oncol 1990, 37:292-295.
83. Metz S.A., Day T.G., Pursell S.H. Adjuvant chemotherapy in a pregnant patient with endodermal sinus tumor of the ovary. Gynecol Oncol 1989, 32:371-374.
84. Kim D.S., Park M.I. Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: a case report. Obstet Gynecol 1989, 73:503-507.
85. Rouzi A.A., Sahly N.N., Sahly N.F., Alahwal M.S. Cisplatinum and docetaxel for ovarian cancer in pregnancy. Arch Gynecol Obstet 2009, 280:823-825.
86. Tabata T., Nishiura K., Tanida K., Kondo E., Okugawa T., Sagawa N. Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer 2008, 18:181-184.
87. Mantovani G., Gramignano G., Mais V., Melis G.B., Parodo G., Carrucciu G.M. Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review. Eur J Obstet Gynecol Reprod Biol 2007, 131:238-239.
88. Modares Gilani M., Karimi Zarchi M., Behtash N., Ghaemmaghami F., Mousavi A.S., Behnamfar F. Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review. Int J Gynecol Cancer 2007, 17:1140-1143.
89. Raghunath R.G., Shashi R.R., Vijaykumar M.A. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report. J Obstet Gynecol India 2006, 56:446-448.
90. Ferrandina G., Distefano M., Testa A., De Vincenzo R., Scambia G. Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. Gynecol Oncol. 2005, 97:693-696.
91. Picone O., Lhommé C., Tournaire M., Pautier P., Camatte S., Vacher-Lavenue M.C., et al. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol 2004, 94:600-604.
92. Huang H.P., Fang C.N., Kan Y.Y. Chemotherapy for ovarian mucinous cyctadenocarcinoma during pregnancy: a case report. Eur J Gynaecol Oncol 2004, 25:635-636.
93. Méndez L.E., Mueller A., Salom E., González-Quintero V.H. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 2003, 102:1200-1202.
94. Sood A.K., Shahin M.S., Sorosky J.I. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001, 83:599-600.
95. Otton G., Higgins S., Phillips K.A., Quinn M. A case of early-stage epithelial ovarian cancer in pregnancy. Int J Gynecol Cancer 2001, 11:413-417.
96. Ohara N., Teramoto K. Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen. Case report. Clin Exp Obstet Gynecol 2000, 27:123-124.
97. Bayhan G., Aban M., Yayla M., Gül T., Yaldiz M., Erden A.C. Cis-platinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report. Eur J Gynaecol Oncol 1999, 20:231-232.
98. Koc O.N., McFee M., Reed E., Gerson S.L. Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J cancer 1994, 30A:716-717.
99. Henderson C.E., Elia G., Garfinkel D., Poirier M.C., Shamkhani H., Runowicz C.D. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol 1993, 49:92-94.
100. King L.A., Nevin P.C., Williams P.P., Carson L.F. Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy. Gynecol Oncol 1991, 41:78-80.
101. Malfetano J.H., Goldkrand J.W. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol 1990, 75:545-547.
102. Palaia I., Pernice M., Graziano M., Bellati F., Panici P.B. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. Am J Obstet Gynecol 2007, 197:e5-e6.
103. Karam A., Feldman N., Holschneider C.H. Neoadjuvant cisplatin and cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol. 2007, 4:375-380.
104. Bader A.A., Petru E., Winter R. Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. Gynecol Oncol 2007, 105:269-272.
105. Benhaim Y., Haie-Meder C., Lhommé C., Pautier P., Duvillard P., Castaigne D., et al. Chemoradiation therapy in pregnant patients treated for advanced-stage cervical carcinoma during the first trimester of pregnancy: report of two cases. Int J Gynecol Cancer 2007, 17:270-274.
106. Caluwaerts S., Van Calsteren K., Mertens L., Lagae L., Moerman P., Hanssens M., et al. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int J Gynecol Cancer 2006, 16:905-908.
107. Germann N., Haie-Meder C., Morice P., L'homme C., Duvillard P., Hacene K., et al. Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol 2005, 16:397-402.
108. Ostrom K., Ben-Arie A., Edwards C., Gregg A., Chiu J.K., Kaplan A.L. Uterine evacuation with misoprostol during radiotherapy for cervical cancer in pregnancy. Int J Gynecol Cancer 2003, 13:340-343.
109. Marana H.R., de Andrade J.M., da Silva Mathes A.C., Duarte G., da Cunha S.P., Bighetti S. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol Oncol 2001, 80:272-274.
110. Tewari K., Cappuccini F., Gambino A., Kohler M.F., Pecorelli S., DiSaia P.J. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer 1998, 82:1529-1534.
111. Lai C.H., Hsueh S., Chang T.C., Tseng C.J., Huang K.G., Chou H.H., et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 1997, 64:456-462.
112. Giacalone P.L., Laffargue F., Benos P., Rousseau O., Hedon B. Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br J Obstet Gynaecol 1996, 103:932-934.
113. Meazza C., Casanova M., Zaffignani E., Clerici C.A., Favini F., Vasquez R., et al. An adolescent with rhabdomyosarcoma during pregnancy. Tumori 2008, 94:431-433.
114. Aboujaoude R., Alvarez J.R., Alvarez M., Al-Khan A. Follicular dendritic cell sarcoma in pregnancy: case report and review of the literature. Am J Perinatol 2006, 23:459-461.
115. Nakajima W., Ishida A., Takahashi M., Hirayama M., Washino N., Ogawa M., et al. Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 week's gestation. J Pediatr Hematol Oncol 2004, 26:308-311.
116. Merimsky O., Le Cesne A. Soft tissue and bone sarcoma in association with pregnancy. Acta Oncol 1998, 37:721-727.
117. Martin D., Winter S.S., Gardner M.O., Nicklaus P. Rhabdomyosarcoma treated with chemotherapy during the first trimester. Obstet Gynecol 1997, 89:828-831.
118. Fernandez H., Diallo A., Baume D., Papiernik E. Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester. Prenat Diagn 1989, 9:681-682.
119. Meador J.M., Armentrout S.A., Slater L.M. Third trimester chemotherapy and neonatal hematopoiesis. Cancer Chemother Pharmacol 1987, 19:177-179.
120. Haerr R.W., Pratt A.T. Multiagent chemotherapy for sarcoma diagnosed during pregnancy. Cancer 1985, 56:1028-1033.
121. Rawlinson K.F., Zubrow A.B., Harris M.A., Jackson U.C., Chao S. Disseminated Kaposi's sarcoma in pregnancy: a manifestation of acquired immune deficiency syndrome. Obstet Gynecol 1984, 63:2S-6S.
122. Blatt J., Mulvihill J.J., Ziegler J.L., Young R.C., Poplack D.G. Pregnancy outcome following cancer chemotherapy. AM J Med 1980, 69:828-832.
123. Ateser G., Yildiz O., Leblebici C., Mandel N.M., Unal F., Turna H., et al. Metastatic primitive neuroectodermal tumor of the ovary in pregnancy. Int J Gynecol Cancer 2007, 17:266-269.
124. Azim H.A., Scarfone G., Peccatori F.A. Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy. J Thorac Oncol 2009, 4:559-560.
125. Gurumurthy M., Koh P., Singh R., Bhide A., Satodia P., Hocking M., et al. Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy. J Perinatol 2009, 29:63-65.
126. García-González J., Cueva J., Lamas M.J., Curiel T., Graña B., López-López R. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy. Clin Trans Oncol 2008, 10:375-376.
127. Zambelli A., Prada G.A., Fregoni V., Ponchio L., Sagrada P., Pavesi L. Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy. Lung cancer 2008, 60:455-457.
128. Garrido M., Clavero J., Huete A., Sánchez C., Solar A., Alvarez M., et al. Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy during pregnancy. Review of cases reported. Lung Cancer 2008, 60:285-290.
129. Kim J.H., Kim H.S., Sung C.W., Kim K.J., Kim C.H., Lee K.Y. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung cancer 2008, 59:270-273.
130. Jänne P.A., Rodriguez-Thompson D., Metcalf D.R., Swanson S.J., Greisman H.A., Wilkins-Haug L., et al. Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy. Oncology 2001, 61:175-183.
131. Kluetz P.G., Edelman M.J. Successful treatment of small cell lung cancer during pregnancy. Lung Cancer 2008, 61:129-130.
132. Li R.H., Tam W.H., Ng P.C., Mok T.S., Tam B., Lau T.K. Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report. J Reprod Med 2007, 52:575-576.
133. Dipaola R.S., Goodin S., Ratzell M., Florczyk M., Karp G., Ravikumar T.S. Chemotherapy for metastatic melanoma during pregnancy. Gynecol Oncol 1997, 66:526-530.
134. Harkin K.P., Drumm J.E., O'Brien P., Daly A. Metastatic malignant melanoma in pregnancy. Ir Med J 1990, 83:116-117.
135. Blumenthal D.T., Parreño M.G., Batten J., Chamberlain M.C. Management of malignant gliomas during pregnancy: a case series. Cancer 2008, 113:3349-3354.
136. Gensheimer M., Jones C.A., Graves C.R., Merchant N.B., Lockhart A.C. Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer Chemother Pharmacol 2009, 63:371-373.
137. Kanate A.S., Auber M.L., Higa G.M. Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer. J Oncol Pharm Pract 2009, 15:5-8.
138. Cheung E.J., Wagner H., Botti J.J., Fedok F., Goldenberg D. Advanced oral tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol 2009, 118:21-26.
139. Raffles A., Williams J., Costeloe K., Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynaecol 1989, 96:1099-1100.
140. Arango H.A., Kalter C.S., Decesare S.L., Fiorica J.V., Lyman G.H., Spellacy W.N. Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol 1994, 84:665-668.
141. Mir O., Berveiller P., Ropert S., Goffinet F., Goldwasser F. Use of platinum derivatives during pregnancy. Cancer 2008, 113:3069-3074.